insights_auto
Outlook: 57.9% bullish·5.3% bearish
Go to analysischevron_right
AVTR:NYSE
Avantor Inc
$15.83
arrow_upward
+1.41%(+0.22) 1D
Nov 3, 11:07:43 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AVTR...
Open
$15.67
High
$16.01
Low
$15.55
Mkt. cap
10.73B
Avg. vol.
10.02M
Volume
1.41M
P/E ratio
31.90
52-wk high
$17.45
52-wk low
$7.26
EPS
$0.50
Beta
0.95
Shares outstanding
677.62M
No. of employees
14K
Open
$15.67
High
$16.01
Low
$15.55
Mkt. cap
10.73B
Avg. vol.
10.02M
Volume
1.41M
P/E ratio
31.90
52-wk high
$17.45
52-wk low
$7.26
EPS
$0.50
Beta
0.95
Shares outstanding
677.62M
No. of employees
14K
News stories
From web sources and news partners
investingLive
·
1 hour ago
The broader US stock indices are making a play to the upside. Nasdaq indices bounce from the 200 day MAs
CNBC
·
21 minutes ago
The most bearish post-midterm scenario that could take the S&P 500 down 10%
TradingView
·
43 minutes ago
S&P 500, Nasdaq edge higher ahead of midterm results; Apple falls
Yahoo Finance
·
2 hours ago
The Average Stock Just Beat the S&P 500 by the Most Since 2009
Profile
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”. Wikipedia
About Avantor Inc
CEO-
Employees13.5K
Founded1904
HeadquartersRadnor Township, Pennsylvania, United States
SectorHealth care
Websiteavantorsciences.com